about
Methimazole-induced insulin autoimmune syndromePosttreatment evaluation of central nervous system gliomas.Pulmonary vascular morphology as an imaging biomarker in chronic thromboembolic pulmonary hypertension.An advanced protocol-driven transition from parenteral prostanoids to inhaled trepostinil in pulmonary arterial hypertensionRelation Between Obesity and Survival in Patients Hospitalized for Pulmonary Arterial Hypertension (from a Nationwide Inpatient Sample Database 2003 to 2011).Physiological Techniques and Pulmonary Hypertension - Left Heart Disease.Trends and outcomes of infective endocarditis in patients on dialysis.Procedural Variations in Performing Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction.Drug-induced pulmonary arterial hypertension: a review.Effect of Chronic Obstructive Pulmonary Disease on In-Hospital Mortality and Clinical Outcomes After ST-Segment Elevation Myocardial Infarction.Albiglutide-induced pancreatitis.Wearable Cardioverter Defibrillator "The Lifevest": Device Design, Limitations, and Areas of Improvement.A Rare Case of Transient Proximal Renal Tubular Acidosis in Pregnancy.Acute kidney injury requiring dialysis and in-hospital mortality in patients with chronic kidney disease and non-ST-segment elevation acute coronary syndrome undergoing early vs delayed percutaneous coronary intervention: A nationwide analysis.Pulmonary haemodynamics during recovery from maximum incremental cycling exercise.Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics.Association between Pulmonary Hypertension and Clinical Outcomes in Hospitalized Sickle Cell Disease Patients.Mortality in sepsis: Comparison of outcomes between patients with demand ischemia, acute myocardial infarction, and neither demand ischemia nor acute myocardial infarctionRelation of Obesity to Outcomes of Hospitalizations for Atrial Fibrillation
P50
Q26740316-D3A72C24-F1CB-44FD-A9C5-C5688E160CD5Q30621046-56E9DC25-CAB8-4485-B095-F4DAADA5DB15Q36881770-5B22581A-AD88-4D5D-9E54-226F86D97A4EQ37555352-CF004093-DF40-4F13-9B34-47A620A9359FQ38732550-DFABC63A-DF72-490E-BB89-532FAAD9111DQ38841272-7B1DDB6C-D3BA-4B89-B7F2-0091D8CBE9ACQ38903906-7F7C8A08-CC7D-4142-8AD8-875556BB0D9EQ39011865-F8AFD85A-2EC6-4DA1-9C17-87179F066F55Q39247400-B842ECE5-D97A-48FB-820A-25CA00A31283Q40252080-7671312D-AACC-4439-9B74-618AAEC91CCBQ42365383-17484209-64AC-4954-A145-D809CE1171C0Q47219808-830FE8CD-0739-43E9-B01F-9DB6C2E2AB50Q47553471-9EC8493D-06D7-4001-8861-BA3A3CE73BC3Q48368949-ED880349-ACB2-4C69-9A49-5C9815E7A79EQ51529590-EC8AC879-EE6F-4CD3-95B4-F40EC035F7B5Q51564356-93E5F434-AB80-49A1-A9A9-35452153F1E4Q52719836-698AEC8D-622B-4EE2-B741-0943D41D2D96Q88723927-D68ED0F9-CAB5-4763-B089-8C2CD096E91CQ92019219-4E12C063-A650-4DE5-AC12-E4B09554AA4B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Manyoo Agarwal
@ast
Manyoo Agarwal
@en
Manyoo Agarwal
@es
Manyoo Agarwal
@nl
Manyoo Agarwal
@sl
type
label
Manyoo Agarwal
@ast
Manyoo Agarwal
@en
Manyoo Agarwal
@es
Manyoo Agarwal
@nl
Manyoo Agarwal
@sl
prefLabel
Manyoo Agarwal
@ast
Manyoo Agarwal
@en
Manyoo Agarwal
@es
Manyoo Agarwal
@nl
Manyoo Agarwal
@sl
P106
P1153
57094572800
P31
P496
0000-0002-0549-9440